0001213900-26-043557
SEC filingAdvanced Biomed Inc. entered into a US$600,000 unsecured loan agreement with Jie Wang on April 13, 2026, bearing 10% annual interest over a six-month term for operational use.
Advanced Biomed Inc. secured a US$600,000 unsecured loan from individual lender Jie Wang, signed by CEO Yi Lu, to support operations amid potential liquidity needs. The 10% interest rate over a six-month horizon, with extension option, provides short-term flexibility without collateral requirements or prepayment penalties. Investors should note the unsecured nature increases default risk for the lender, though repayment obligations could pressure near-term cash flows if not managed. New York jurisdiction standardizes dispute resolution. This financing reflects reliance on private debt, distinct from equity dilution.